Lauren E. Bloomfield

270 Joondalup Dr
Joondalup, WA 6027, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Post-licensure safety monitoring of nirsevimab in Western Australia 2024.

Post-licensure safety monitoring of nirsevimab in Western Australia 2024.

Journal: Vaccine

Published: December 18, 2025

Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection.

Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection.

Journal: Epidemiology and infection

Published: September 18, 2025

More evidence needed for maternal RSVpreF protection to age 6 months.

More evidence needed for maternal RSVpreF protection to age 6 months.

Journal: The Lancet. Infectious diseases

Published: May 20, 2025

Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)-associated hospitalisations, Western Australia, 2024: a population-based analysis.

Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)-associated hospitalisations, Western Australia, 2024: a population-based analysis.

Journal: The Medical journal of Australia

Published: January 26, 2025

Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024.

Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024.

Journal: The Journal of infection

Published: December 22, 2024

Nuvaxovid NVX-CoV2373 vaccine safety profile: real-world data evidence after 100,000 doses, Australia, 2022 to 2023.

Nuvaxovid NVX-CoV2373 vaccine safety profile: real-world data evidence after 100,000 doses, Australia, 2022 to 2023.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: December 13, 2024

Community-associated methicillin-resistant Staphylococcus aureus in the Kimberley region of Western Australia, epidemiology and burden on hospitals.

Community-associated methicillin-resistant Staphylococcus aureus in the Kimberley region of Western Australia, epidemiology and burden on hospitals.

Journal: Epidemiology and infection

Published: November 27, 2024

Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse Events.

Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse Events.

Journal: Drug safety

Published: October 24, 2024

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial.

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial.

Journal: JMIR serious games

Published: May 20, 2024

Using data linkage to monitor COVID-19 vaccination: development of a vaccination linked data repository.

Using data linkage to monitor COVID-19 vaccination: development of a vaccination linked data repository.

Journal: International journal of population data science

Published: August 31, 2023

Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.

Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.

Journal: The Medical journal of Australia

Published: July 24, 2023

SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022.

SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022.

Journal: Emerging infectious diseases

Published: May 04, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026